Mayne Pharma Group Limited

Symbole: MYX.AX

ASX

6.8

AUD

Prix du marché aujourd'hui

  • -2.3865

    Ratio P/E

  • -0.0091

    Ratio PEG

  • 578.51M

    Cap MRK

  • 0.00%

    Rendement DIV

Mayne Pharma Group Limited Structure de gestion

Informations sur la direction

Nom de l'entrepriseTitre de l'entreprise
Dr. Andrew O. Herdman Ph.D.Vice President of Group HR
Mr. Brenton WalterFinancial Controller
Ms. Laura LoftusAssociate Gen. Counsel & Company Sec.
Dr. Frank Casty M.D.Executive Vice President & Global Chief Medical Officer
Mr. Hemanshu N. PandyaSenior Vice President & Head of Generic Product Division
Mr. Shawn Patrick O'Brien B.ScChief Executive Officer, MD & Director
Ms. Kimberly Parker J.D.Executive Vice President & Gen. Counsel
Mr. Daniel MooreExecutive Vice President of Commercial
Mr. Aaron GrayChief Financial Officer
Mr. Brant SchofieldExecutive Vice President of Corporation Devel.
Ms. Erinn NathanielDirector of Global HR
Ms. Lisa PendleburyVice President of Investor Relations & Communications
Mr. Stefan J. CrossPres of International Operations
Mr. Gerard G. Nahum M.D.Chief Medical Officer